Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis.
addiction
craving
dorsolateral prefrontal cortex
eating disorder
gambling disorder
substance use disorder
transcranial magnetic stimulation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 Jan 2022
26 Jan 2022
Historique:
received:
22
12
2021
revised:
14
01
2022
accepted:
19
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
Addiction is a mental disorder with limited available treatment options. The therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) on it, by targeting craving in particular, has been explored with heterogenous results. This meta-analysis uses updated evidence to assess overall rTMS efficacy on craving, differential effects between addiction types clustered into three groups (depressant (alcohol, cannabis, opiate), stimulant (nicotine, cocaine, methamphetamine), and behavioral addiction (gambling, eating disorder)), and stimulation settings. Studies on substance use, gambling, and eating disorders are included, with unrestricted stimulation settings, by searching the PubMed, Embase, PsycINFO, and Cochrane databases up to 30 April 2020. A total of 34 eligible studies (42 units of analysis) were identified. Because of highly significant heterogeneity in primary results, a sensitivity analysis was performed on a remaining sample of 26 studies (30 units of analysis). Analyses performed using random effects model revealed a small effect size favoring active rTMS over shamTMS stimulation in the reduction in craving. We found a significant difference between addiction types, with a persistent small effect only for stimulant and behavioral groups. In these groups we found no difference between the different combinations of target and frequency of stimulation, but a significant correlation between number of sessions and craving reduction. In conclusion, efficacy of rTMS on craving in stimulant and behavioral addiction was highlighted, but recommendations on optimal stimulation settings and its clinical application await further research.
Identifiants
pubmed: 35160085
pii: jcm11030624
doi: 10.3390/jcm11030624
pmc: PMC8836499
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Int J Eat Disord. 2009 Sep;42(6):571-4
pubmed: 19172600
J Neurosci. 2000 May 15;20(10):3864-73
pubmed: 10804226
Neuroreport. 1997 Aug 18;8(12):2787-91
pubmed: 9295118
Neurosci Biobehav Rev. 2014 Jan;38:1-16
pubmed: 24211373
World Psychiatry. 2021 Oct;20(3):397-404
pubmed: 34505368
Biol Psychiatry. 2010 Apr 15;67(8):793-5
pubmed: 20060105
PLoS One. 2009 Aug 21;4(8):e6725
pubmed: 19696930
Neuropsychopharmacology. 2009 Oct;34(11):2359-67
pubmed: 19606086
J Addict Med. 2020 Jul/Aug;14(4):272-274
pubmed: 31725426
Addiction. 2009 Apr;104(4):653-60
pubmed: 19183128
Nat Rev Neurosci. 2011 Oct 05;12(11):685-700
pubmed: 21971065
Nutrients. 2014 Sep 16;6(9):3653-71
pubmed: 25230209
Alcohol Alcohol. 2013 Sep-Oct;48(5):552-7
pubmed: 23709633
Neurosci Biobehav Rev. 2014 Nov;47:592-613
pubmed: 25454360
Res Synth Methods. 2017 Sep;8(3):263-274
pubmed: 28429470
Asian J Gambl Issues Public Health. 2016;6(1):1
pubmed: 27630808
Brain. 1994 Aug;117 ( Pt 4):847-58
pubmed: 7922470
Front Psychiatry. 2011 Nov 29;2:64
pubmed: 22144966
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):599-609
pubmed: 29776789
Neurosci Biobehav Rev. 2015 Dec;59:184-200
pubmed: 26449761
Neuropsychobiology. 2005;51(2):59-66
pubmed: 15741745
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Front Psychiatry. 2011 Mar 14;2:9
pubmed: 21556279
Am J Addict. 2017 Dec;26(8):776-779
pubmed: 29134789
Eur Neuropsychopharmacol. 2017 May;27(5):450-461
pubmed: 28390775
Brain. 2003 Dec;126(Pt 12):2609-15
pubmed: 12937078
World J Biol Psychiatry. 2011 Sep;12 Suppl 1:57-62
pubmed: 21905997
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Consult Clin Psychol. 2012 Feb;80(1):54-65
pubmed: 22103958
Front Psychiatry. 2019 May 07;10:272
pubmed: 31133889
Brain Stimul. 2015 Nov-Dec;8(6):1168-74
pubmed: 26590478
Drug Alcohol Depend. 2017 Jun 1;175:84-91
pubmed: 28410525
Neurosci Biobehav Rev. 2010 Mar;34(4):606-23
pubmed: 19961872
Ann N Y Acad Sci. 2012 Feb;1248:1-17
pubmed: 22172057
J Consult Clin Psychol. 2004 Feb;72(1):72-80
pubmed: 14756616
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2472-80
pubmed: 23916527
Expert Opin Pharmacother. 2014 Mar;15(4):471-81
pubmed: 24456374
Addiction. 2010 Jan;105(1):49-55
pubmed: 20078462
Eur Psychiatry. 2017 Mar;41:68-74
pubmed: 28049084
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003023
pubmed: 17636713
Curr Drug Abuse Rev. 2011 Mar;4(1):42-56
pubmed: 21466500
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109938
pubmed: 32234509
Psychol Addict Behav. 2012 Sep;26(3):536-49
pubmed: 22121917
Eur Eat Disord Rev. 2016 Nov;24(6):474-481
pubmed: 27633286
Drug Alcohol Depend. 2013 Dec 1;133(2):641-6
pubmed: 24028801
Harv Rev Psychiatry. 2019 Sep/Oct;27(5):326-331
pubmed: 31385813
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Am J Addict. 2016 Jan;25(1):28-30
pubmed: 26692110
Front Psychiatry. 2020 Feb 28;11:158
pubmed: 32180745
Psychiatr Clin North Am. 2012 Jun;35(2):425-39
pubmed: 22640764
Behav Neurol. 2014;2014:815215
pubmed: 24803733
Neuroimage. 2005 Oct 15;28(1):22-9
pubmed: 16002305
Drug Alcohol Depend. 2008 Mar 1;93(3):252-9
pubmed: 18063320
Front Neurosci. 2019 Oct 18;13:1095
pubmed: 31680830
Neuropharmacology. 2009;56 Suppl 1:3-8
pubmed: 18617195
Drug Alcohol Depend. 2012 Jan 1;120(1-3):209-13
pubmed: 21855234
J Behav Addict. 2018 Mar 1;7(1):126-136
pubmed: 29463098
Neuron. 2005 Jan 20;45(2):201-6
pubmed: 15664172
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
J Clin Neurophysiol. 2002 Aug;19(4):361-70
pubmed: 12436090
J Neuropsychiatry Clin Neurosci. 2017 Spring;29(2):160-171
pubmed: 27707195
Brain Res. 2015 Dec 2;1628(Pt A):199-209
pubmed: 25770818
Transl Psychiatry. 2017 Jan 3;7(1):e992
pubmed: 28045460
Addiction. 2019 Dec;114(12):2137-2149
pubmed: 31328353
Appl Psychophysiol Biofeedback. 2005 Sep;30(3):195-204
pubmed: 16167185
Eur Addict Res. 2014;20(5):248-53
pubmed: 24924851
Neuron. 2011 Feb 24;69(4):695-712
pubmed: 21338880
Brain Stimul. 2016 Nov - Dec;9(6):867-875
pubmed: 27350401
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008537
pubmed: 21678378
Psychol Med. 2008 Oct;38(10):1465-74
pubmed: 17976250
Curr Drug Abuse Rev. 2011 Sep;4(3):201-7
pubmed: 21999695
Ann N Y Acad Sci. 2014 Oct;1327:79-93
pubmed: 25069523
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Clin Neurophysiol. 2014 Nov;125(11):2150-2206
pubmed: 25034472
Psychol Addict Behav. 2009 Sep;23(3):512-22
pubmed: 19769435
Am J Drug Alcohol Abuse. 2018;44(1):47-55
pubmed: 28806104
Addiction. 2011 May;106(5):866-7
pubmed: 21477226
Biol Psychiatry. 2011 Oct 15;70(8):794-799
pubmed: 21762878
PLoS One. 2016 Mar 23;11(3):e0148606
pubmed: 27008620
Psychiatr Prax. 2003 May;30 Suppl 2:S129-31
pubmed: 14509058
Psychiatry Res. 2018 Apr;262:363-372
pubmed: 28951141
Biol Psychiatry. 2021 Dec 6;:
pubmed: 35067356
Can J Physiol Pharmacol. 2015 Apr;93(4):283-90
pubmed: 25730614
Neurosci Biobehav Rev. 2017 Jul;78:104-116
pubmed: 28456569
Psychopharmacology (Berl). 2007 Apr;191(3):391-431
pubmed: 17072591
Clin Psychol Rev. 2009 Aug;29(6):519-34
pubmed: 19577831
Neuropsychol Rev. 2007 Sep;17(3):337-45
pubmed: 17680368
Eur Neuropsychopharmacol. 2020 Feb;31:158-161
pubmed: 31902567
Drug Alcohol Depend. 2009 Aug 1;103(3):131-6
pubmed: 19443131
Biol Psychiatry. 2016 Aug 1;80(3):e13-4
pubmed: 26995024
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3277-86
pubmed: 18640914
JAMA Psychiatry. 2018 Nov 1;75(11):1199-1201
pubmed: 30208372
Biol Psychiatry. 2005 Nov 15;58(10):840-2
pubmed: 16084855
Drug Alcohol Depend. 2016 Jan 1;158:147-53
pubmed: 26679060
Alcohol Clin Exp Res. 2016 Jan;40(1):196-205
pubmed: 26727534
Curr Pharm Des. 2011;17(14):1389-95
pubmed: 21524264
Am J Psychiatry. 2002 Oct;159(10):1642-52
pubmed: 12359667
J Nutr. 2009 Mar;139(3):620-2
pubmed: 19176747
Am J Addict. 2019 Nov;28(6):431-454
pubmed: 31513324
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):E30-1
pubmed: 21677218
Brain Stimul. 2009 Oct;2(4):188-200
pubmed: 20633419
Clin Neurophysiol. 2005 Apr;116(4):775-9
pubmed: 15792886
Biol Psychiatry. 2013 Apr 15;73(8):714-20
pubmed: 23485014
Brain Stimul. 2019 May - Jun;12(3):606-618
pubmed: 30612944
Neuropsychopharmacology. 2016 Jan;41(2):628-37
pubmed: 26119472
Neuropsychopharmacology. 2020 Apr;45(5):842-850
pubmed: 31711065
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
J Neurosci. 2005 Apr 13;25(15):3932-9
pubmed: 15829645
Science. 1997 Oct 3;278(5335):52-8
pubmed: 9311926
Drug Alcohol Depend. 2017 May 1;174:98-105
pubmed: 28319755
Curr Psychiatry Rep. 2012 Aug;14(4):406-14
pubmed: 22644309
Arch Gen Psychiatry. 2006 Mar;63(3):324-31
pubmed: 16520439
Neurology. 2001 Nov 27;57(10):1899-901
pubmed: 11723286
Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286
pubmed: 27009521
JAMA Netw Open. 2020 Mar 2;3(3):e200910
pubmed: 32167568
Brain Stimul. 2014 Mar-Apr;7(2):226-33
pubmed: 24468092
Psychosom Med. 2017 Jan;79(1):2-13
pubmed: 27428861
Am J Psychiatry. 2005 Aug;162(8):1403-13
pubmed: 16055761
Eur J Neurosci. 2008 Feb;27(3):765-74
pubmed: 18279329
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Psychopharmacology (Berl). 2014 May;231(9):1897-912
pubmed: 24500676